How long does it usually take to develop the concept of a clinical or observational study and its protocol?
Developing the concept of a clinical or observational study, along with the full study protocol, is one of the key stages of project preparation and requires sufficient time, experience, and close collaboration among multiple specialists. In practice, there is no single universal timeline, as the duration of this process depends on the complexity of the study, its phase, its nature (interventional vs. observational), as well as the sponsor’s regulatory and organizational requirements.
For relatively simple observational studies with a clearly defined objective and standard methodology, the development of the concept and protocol may take approximately 4 weeks to 2–3 months. During this time, key elements are defined, including study objectives, the study population, the data collection scheme, inclusion and exclusion criteria, the scope of observation, and the statistical analysis plan. At this stage, particular emphasis is placed on aligning the study design with real-world clinical practice and minimizing the burden on study sites and patients.
In the case of interventional clinical trials, the process is significantly more complex. Developing a complete study concept and clinical trial protocol typically takes 8 to 12 weeks, and in more advanced or innovative projects it may extend to several months. This is due to the need for detailed planning of endpoints, treatment regimens, visit schedules, safety procedures, adverse event reporting rules, as well as data monitoring and analysis plans.
An important factor influencing the time required to prepare the protocol is the need to ensure full compliance with applicable regulations, Good Clinical Practice (GCP) guidelines, and the sponsor’s internal procedures. The protocol must be sufficiently precise to serve as a foundation for subsequent stages of the process, such as preparing documentation for ethics committees, regulatory authorities, and initiating the study at investigational sites.
In practice, protocol development almost always involves several rounds of consultations and revisions. Feedback from the medical team, statisticians, quality departments, pharmacovigilance (PhV), CROs, and investigators is an essential part of the process and has a direct impact on the final quality of the document. Although this extends the preparation timeline, it significantly reduces the risk of operational and regulatory issues at later stages of study execution.
It is worth emphasizing that a well-designed concept and a robust clinical or observational study protocol form the foundation of the entire project. Investing adequate time at this stage helps avoid costly amendments, recruitment delays, and ambiguous data interpretations during the study.
In summary, developing the concept and protocol for clinical and observational studies typically takes from several weeks to several months, depending on the scale and complexity of the project. This is a stage that should not be rushed at the expense of quality, as its robustness directly translates into efficient study execution and the credibility of the results obtained.
If you would like to save time, validate an initial study concept or protocol, and consequently move more quickly into the study execution phase, we encourage you to consult with our experts.
